H Liu1, Y Tang1, X Liu2, Q Zhou2, X Xiao2, F Lan3, X Li4, R Hu2, Y Xiong2, T Peng2. 1. Obstetrics & Gynecology Hospital, Fudan University, 419 Fangxie Road, Shanghai 200011, China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, 413 Zhaozhou Road, Shanghai 200011, China. 2. Obstetrics & Gynecology Hospital, Fudan University, 419 Fangxie Road, Shanghai 200011, China. 3. Institute of Biomedical Science, Fudan University, 138 Yixueyuan Road, Shanghai 200032, China. 4. Obstetrics & Gynecology Hospital, Fudan University, 419 Fangxie Road, Shanghai 200011, China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, 413 Zhaozhou Road, Shanghai 200011, China. Electronic address: xiaotianli555@163.com.
Abstract
INTRODUCTION: Disruption of the 14-3-3 tau (YWHAQ) gene has been shown to be involved in preeclampsia (PE). The YWHAQ promoter could be differentially regulated by methylation in severe PE patients. METHODS: Placental genomic DNA from patients with severe PE (n = 21) and controls who experienced a normal pregnancy (n = 16) was analyzed using dot-blot and immunohistochemistry. The placental methylation patterns of YWHAQ, expression of 14-3-3 tau and ten-eleven translocation (TET), were confirmed by bisulfite sequencing, immunohistochemistry, western blot and real-time PCR, respectively. RESULTS: Genomic 5 hmC (P < 0.001), expression of 14-3-3 tau (P < 0.01) and TET (P < 0.05) were down-regulated, whereas 5 mC was up-regulated (P < 0.001) in preeclamptic placentas. Significant hypermethylation of the YWHAQ promoter was detected in PE placentas compared with control samples (19.1% vs. 9.4%, P = 0.0095). PE-specific hypermethylation of CpG2 - 4, CpG9, CpG17, CpG19 was identified in PE patients compared with controls (CpG2: 13.3% vs. 2.5%, P < 0.0001; CpG3: 14.8% vs. 3.1%, P < 0.0001; CpG4: 19.5% vs. 5.0%, P < 0.0001; CpG9: 15.7% vs. 5.0%, P = 0.0018; CpG17: 16.2% vs. 6.3%, P = 0.0003; and CpG19: 78.1% vs. 59.4%, P < 0.0001). DISCUSSION: The observed participation of 14-3-3 tau in the regulation of the placental epigenome may participate in the molecular mechanisms that govern the pathological process of PE, although this requires further evaluation.
INTRODUCTION: Disruption of the 14-3-3 tau (YWHAQ) gene has been shown to be involved in preeclampsia (PE). The YWHAQ promoter could be differentially regulated by methylation in severe PE patients. METHODS: Placental genomic DNA from patients with severe PE (n = 21) and controls who experienced a normal pregnancy (n = 16) was analyzed using dot-blot and immunohistochemistry. The placental methylation patterns of YWHAQ, expression of 14-3-3 tau and ten-eleven translocation (TET), were confirmed by bisulfite sequencing, immunohistochemistry, western blot and real-time PCR, respectively. RESULTS: Genomic 5 hmC (P < 0.001), expression of 14-3-3 tau (P < 0.01) and TET (P < 0.05) were down-regulated, whereas 5 mC was up-regulated (P < 0.001) in preeclamptic placentas. Significant hypermethylation of the YWHAQ promoter was detected in PE placentas compared with control samples (19.1% vs. 9.4%, P = 0.0095). PE-specific hypermethylation of CpG2 - 4, CpG9, CpG17, CpG19 was identified in PE patients compared with controls (CpG2: 13.3% vs. 2.5%, P < 0.0001; CpG3: 14.8% vs. 3.1%, P < 0.0001; CpG4: 19.5% vs. 5.0%, P < 0.0001; CpG9: 15.7% vs. 5.0%, P = 0.0018; CpG17: 16.2% vs. 6.3%, P = 0.0003; and CpG19: 78.1% vs. 59.4%, P < 0.0001). DISCUSSION: The observed participation of 14-3-3 tau in the regulation of the placental epigenome may participate in the molecular mechanisms that govern the pathological process of PE, although this requires further evaluation.
Authors: Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang Journal: Physiol Rev Date: 2018-07-01 Impact factor: 37.312
Authors: Melissa A Richard; Tianxiao Huan; Symen Ligthart; Rahul Gondalia; Min A Jhun; Jennifer A Brody; Marguerite R Irvin; Riccardo Marioni; Jincheng Shen; Pei-Chien Tsai; May E Montasser; Yucheng Jia; Catriona Syme; Elias L Salfati; Eric Boerwinkle; Weihua Guan; Thomas H Mosley; Jan Bressler; Alanna C Morrison; Chunyu Liu; Michael M Mendelson; André G Uitterlinden; Joyce B van Meurs; Oscar H Franco; Guosheng Zhang; Yun Li; James D Stewart; Joshua C Bis; Bruce M Psaty; Yii-Der Ida Chen; Sharon L R Kardia; Wei Zhao; Stephen T Turner; Devin Absher; Stella Aslibekyan; John M Starr; Allan F McRae; Lifang Hou; Allan C Just; Joel D Schwartz; Pantel S Vokonas; Cristina Menni; Tim D Spector; Alan Shuldiner; Coleen M Damcott; Jerome I Rotter; Walter Palmas; Yongmei Liu; Tomáš Paus; Steve Horvath; Jeffrey R O'Connell; Xiuqing Guo; Zdenka Pausova; Themistocles L Assimes; Nona Sotoodehnia; Jennifer A Smith; Donna K Arnett; Ian J Deary; Andrea A Baccarelli; Jordana T Bell; Eric Whitsel; Abbas Dehghan; Daniel Levy; Myriam Fornage Journal: Am J Hum Genet Date: 2017-11-30 Impact factor: 11.025
Authors: A Cirkovic; V Garovic; J Milin Lazovic; O Milicevic; M Savic; N Rajovic; N Aleksic; T Weissgerber; A Stefanovic; D Stanisavljevic; N Milic Journal: Biol Sex Differ Date: 2020-07-06 Impact factor: 5.027